Competitive NMDA receptor antagonist.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Sold with the permission of Eli Lilly and Company.
Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice.
Borowicz et al.
Competitive and non-competitive NMDA antagonists induce similar limbic degeneration.
The citations listed below are publications that use Tocris products. Selected citations for LY 235959 include:
Showing Results 1 - 2 of 2